Journal for ImmunoTherapy of Cancer (Nov 2021)
225 Optimal-affinity MAGE-A1-specific T cell receptors (TCRs) generated using the humanized TCR-transgenic mouse platform HuTCR are superior to human donor-derived TCRs
Abstract
No abstracts available.